Life Sciences companies and their Social Media usage


Published on

In today's social media boom, the Life Sciences industry has remained cautious in its social endeavors, owing to lack of clarity on guidelines, especially wrt adverse event reporting.

In the view of the latest FDA guidelines, this white paper aims to shed light on the realities of Adverse Event Reporting in social media.

Published in: Technology
  • Be the first to comment

  • Be the first to like this

No Downloads
Total views
On SlideShare
From Embeds
Number of Embeds
Embeds 0
No embeds

No notes for slide

Life Sciences companies and their Social Media usage

  1. 1. Life Sciences & Social Media Impact of FDA Guidance1 © 2012 WIPRO LTD | WWW.WIPRO.COM
  2. 2. HIGHLIGHTS Why Life Sciences Companies Should Engage on Social Media In todays social media boom, the Life Sciences industry has remained cautious in its social endeavors, owing to lack of clarity on guidelines, especially wrt adverse event reporting. In the view of the latest FDA guidelines, this white paper aims to shed light on the realities of Adverse Event Reporting in social media.2 © 2012 WIPRO LTD | WWW.WIPRO.COM
  3. 3. Shying Away from Social Media What is an adverse event? An adverse event (AE) is defined as any unfavorable and unintended sign including abnormal laboratory finding, symptom or disease associated with the use of a medical treatment or procedure, regardless of whether it is considered related to the medical treatment or procedure. What do the FDA guidelines say? According to guidelines, when a Life Sciences company has knowledge of any adverse event , it has an obligation to file a report with the FDA through the Form 3500A-Mandatory Reporting. Why are Life Sciences companies shying away from Social Media? Considering the nature of social media Life Sciences companies are concerned about consumer discussions that would indicate an adverse experience.3 © 2012 WIPRO LTD | WWW.WIPRO.COM
  4. 4. Key Findings of Wipros Social Listening Wipro used its Social Media Monitoring Platform to conduct an analysis of 2100 messages related to Pharma and Medical Device products posted online across various internet forums. The research revealed that for all posts containing mentions of the 13 brands considered for this study:  Only 3% of all posts have mention of an Adverse Reaction  Only 0.38% messages actually qualify for an Adverse Event Reporting  The incidence of Adverse Events is almost same for Pharma Drugs and Medical Devices  The messages with mention of Adverse Events are considerably less for Medical Devices as compared to Pharma Drugs4 © 2012 WIPRO LTD | WWW.WIPRO.COM
  5. 5. FDA Guidance on AE Reporting  The company has the choice to respond to Are Life Sciences companies that unsolicited requests or not are monitoring social media obligated to respond to any unsolicited requests on consumer-  If the company chooses to respond, the actual generated media? response can only be provided in a private, one-on- one communication The FDA guidance does provide some insight into FDA’s stance on Social Media. A Life Sciences company that aggressively monitors social media may pick up the occasional AE within patient or physician online discussion. However an instance qualifying for Adverse Event Reporting would be encountered very rarely, with a volume that would be entirely manageable within the company‘s broader AE monitoring programs.5 © 2012 WIPRO LTD | WWW.WIPRO.COM
  6. 6. Benefits of Engaging on Social Media Improved understanding of patients concerns Aversion of risk of unapproved usage Better understanding of patients experiences Competitor analysis Engagement with caregivers6 © 2012 WIPRO LTD | WWW.WIPRO.COM
  7. 7. Conclusion  The FDA guidance on the responsibilities of Life Sciences companies monitoring the social media comes as a sigh of relief.  The benefits of social listening far outweigh the concerns that companies share.  The future of Life Sciences marketing is in being part of conversations in the online space.7 © 2012 WIPRO LTD | WWW.WIPRO.COM
  8. 8. For more details please visit the link below: sciences_companies_should_engage_on_social_media.pdf8 © 2012 WIPRO LTD | WWW.WIPRO.COM
  9. 9. About Wipro Council for Industry Research Wipro set up the Council for Industry Research, comprised of domain and technology experts from the organization, to address the needs of customers. It specifically surveys innovative strategies that will help customers gain competitive advantage in the market. The Council, in collaboration with leading academic institutions and industry bodies, studies market trends to help equip organizations with insights to facilitate their IT and business strategies. For more information on the Research Council visit or mail wipro.insights@wipro.com9 © 2012 WIPRO LTD | WWW.WIPRO.COM
  10. 10. About Wipro Technologies Wipro Technologies, the global IT business of Wipro Limited (NYSE:WIT) is a leading Information Technology, Consulting and Outsourcing company, that delivers solutions to enable its clients do business better. Wipro Technologies delivers winning business outcomes through its deep industry experience and a 360 degree view of “Business through Technology” – helping clients create successful and adaptive businesses. A company recognised globally for its comprehensive portfolio of services, a practitioner’s approach to delivering innovation and an organization wide commitment to sustainability, Wipro Technologies has over 135,000 employees and clients across 54 countries. For more information, please visit www.wipro.com10 © 2012 WIPRO LTD | WWW.WIPRO.COM
  11. 11. Thank You ©Wipro Limited, 2012. All rights reserved. For more information visit No part of this document may be reproduced in whole or in part without the written permission of the authors. Wipro is not liable for any business outcome based on the views presented in this document. For specific implementation clients should take advise from their client engagement manager.11 © 2012 WIPRO LTD | WWW.WIPRO.COM